Naltrexone and Alpha Lipoic acid for Pancreatic Cancer

In the latest issue of Integrative Cancer Therapies, a case of 3 patients with pancreatic cancer were treated with intravenous alpha lipoic acid and low dose naltrexone. What’s astonishing is that the patients are still alive, 2 of which were already cancer free based on their PET scan.

This is an ongoing trial in a New Mexico Integrative Center.

I hope this study will be more available to all pancreatic cancer patients.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s